Covenant Asset Management, LLC Eli Lilly & CO Put Options Transaction History

Covenant Asset Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $3.86 Million - $4.8 Million	5,000 New	5,000 $4.43 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $6.04 Million - $7.12 Million	11,500 New	11,500 $6.7 Million
Q4 2022 Jan 24, 2023	SELL	$321.55 - $374.67 $11.3 Million - $13.1 Million	-35,000 Reduced 89.74%	4,000 $0
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $11.6 Million - $13.2 Million	39,000 New	39,000 $12.6 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Asset Management, LLC with notifications on news.